References
- Shire SJ, Shahrokh Z, Liu J. Challenges in the development of high protein concentration formulations. J Pharm Sci. 2004;93:1390–12. doi:https://doi.org/10.1002/jps.20079.
- Daugherty AL, Mrsny RJ. Formulation and delivery issues for monoclonal antibody therapeutics. Adv Drug Deliv Rev. 2006;58:686–706. doi:https://doi.org/10.1016/j.addr.2006.03.011.
- Agrawal NJ, Helk B, Kumar S, Mody N, Sathish HA, Samra HS, Buck PM, Li L, Trout BL. Computational tool for the early screening of monoclonal antibodies for their viscosities. MAbs. 2016;8:43–48. doi:https://doi.org/10.1080/19420862.2015.1099773.
- Kamerzell TJ, Esfandiary R, Joshi SB, Middaugh CR, Volkin DB. Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development. Adv Drug Deliv Rev. 2011;63:1118–59. doi:https://doi.org/10.1016/j.addr.2011.07.006.
- Yadav S, Laue TM, Kalonia DS, Singh SN, Shire SJ. The influence of charge distribution on self-association and viscosity behavior of monoclonal antibody solutions. Mol Pharm. 2012;9:791–802. doi:https://doi.org/10.1021/mp200566k.
- Wang S, Zhang N, Hu T, Dai W, Feng X, Zhang X, Qian F. Viscosity-lowering effect of amino acids and salts on highly concentrated solutions of two IgG1 monoclonal antibodies. Mol. Pharm. 2015;12:4478–87. doi:https://doi.org/10.1021/acs.molpharmaceut.5b00643.
- Shukla D, Trout BL. Interaction of arginine with proteins and the mechanism by which it inhibits aggregation. J Phys Chem B. 2010;114:13426–38. doi:https://doi.org/10.1021/jp108399g.
- MacKerell AD, Bashford D, Bellott M, Dunbrack RL, Evanseck JD, Field MJ, Fischer S, Gao J, Guo H, Ha S, et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins†. J Phys Chem B. 1998;102:3586–616. doi:https://doi.org/10.1021/jp973084f.
- Ponder JW, Case DA. Force fields for protein simulations. Adv Protein Chem. 2003;66:27–85.
- Yin D, Mackerell AD. Combined Ab initio/empirical approach for optimization of Lennard-Jones parameters. J Comput Chem. 1998;19:334–48. doi:https://doi.org/10.1002/(SICI)1096-987X(199802)19:3<334::AID-JCC7>3.0.CO;2-U.
- Cloutier T, Sudrik C, Mody N, Sathish HA, Trout BL. Molecular computations of preferential interaction coefficients of IgG1 monoclonal antibodies with sorbitol, sucrose, and trehalose and the impact of these excipients on aggregation and viscosity. Mol Pharma. 2019;16:3657–64. doi:https://doi.org/10.1021/acs.molpharmaceut.9b00545.
- Lee JC, Timasheff SN. The stabilization of proteins by sucrose. J Biol Chem. 1981;256:7193–201.
- Xie G, Timasheff SN. Mechanism of the stabilization of ribonuclease A by Sorbitol: preferential hydration is greater for the denatured than for the native protein. Protein Sci. 1997;6:211–21. doi:https://doi.org/10.1002/pro.5560060123.
- Xie G, Timasheff SN. The thermodynamic mechanism of protein stabilization by trehalose. Biophys Chem. 1997;64:25–43. doi:https://doi.org/10.1016/S0301-4622(96)02222-3.
- Sudrik C, Cloutier T, Pham P, Samra HS, Trout BL. Preferential interactions of trehalose, L-arginine.HCl and sodium chloride with therapeutically relevant IgG1 monoclonal antibodies. MAbs. 2017;9:1155–68. doi:https://doi.org/10.1080/19420862.2017.1358328.
- Dear BJ, Hung JJ, Truskett TM, Johnston KP. Contrasting the influence of cationic amino acids on the viscosity and stability of a highly concentrated monoclonal antibody. Pharm Res. 2017;34:193–207. doi:https://doi.org/10.1007/s11095-016-2055-5.
- Hung JJ, Dear BJ, Dinin AK, Borwankar AU, Mehta SK, Truskett TT, Johnston KP. Improving viscosity and stability of a highly concentrated monoclonal antibody solution with concentrated proline. Pharm. Res. 2018;35:133. doi:https://doi.org/10.1007/s11095-018-2398-1.
- Binabaji E, Ma J, Zydney AL. Intermolecular interactions and the viscosity of highly concentrated monoclonal antibody solutions. Pharm Res. 2015;32:3102–09. doi:https://doi.org/10.1007/s11095-015-1690-6.
- Inoue N, Takai E, Arakawa T, Shiraki K. Specific decrease in solution viscosity of antibodies by arginine for therapeutic formulations. Mol Pharma. 2014;11:1889–96. doi:https://doi.org/10.1021/mp5000218.
- Shukla D, Trout BL. Preferential interaction coefficients of proteins in aqueous arginine solutions and their molecular origins. J Phys Chem B. 2011;115:1243–53. doi:https://doi.org/10.1021/jp108586b.
- Reza M, How HB. Can a Free Amino Acid Stabilize a Protein? Insights from Molecular Dynamics Simulation. J Soln Chem. 2015;44:45–53. doi:https://doi.org/10.1007/s10953-015-0291-7.
- Banks DD, Latypov RF, Ketchem RR, Woodard J, Scavezze JL, Siska CC, Razinkov VI. Native-state solubility and transfer free energy as predictive tools for selecting excipients to include in protein formulation development studies. J. Pharm. Sci. 2012;101:2720–32. doi:https://doi.org/10.1002/jps.23219.
- Li J, Garg M, Shah D, Rajagopalan R. Solubilization of aromatic and hydrophobic moieties by arginine in aqueous solutions. J. Chem. Phys. 2010;133:054902. doi:https://doi.org/10.1063/1.3469790.
- Li L, Kumar S, Buck PM, Burns C, Lavoie J, Singh SK, Warne NW, Nichols P, Luksha N, Boardman D, et al. Concentration dependent viscosity of monoclonal antibody solutions: explaining experimental behavior in terms of molecular properties. Pharm. Res. 2014;31:3161–78. doi:https://doi.org/10.1007/s11095-014-1409-0.
- Chennamsetty N, Voynov V, Kayser V, Helk B, Trout BL. Design of therapeutic proteins with enhanced stability. PNAS. 2009;106:11937–42. doi:https://doi.org/10.1073/pnas.0904191106.
- Tomar DS, Kumar S, Singh SK, Goswami S, Li L. Molecular basis of high viscosity in concentrated antibody solutions: strategies for high concentration drug product development. MAbs. 2016;8:216–28. doi:https://doi.org/10.1080/19420862.2015.1128606.
- Sharma VK, Patapoff TW, Kabakoff B, Pai S, Hilario E, Zhang B, Li C, Borisov O, Kelley RF, Chorny I, et al. In silico selection of therapeutic antibodies for development: viscosity, clearance, and chemical stability. PNAS. 2014;111:18601–06. doi:https://doi.org/10.1073/pnas.1421779112.
- Sudrik C, Cloutier T, Mody N, Sathish HA, Trout BL. Preferential exclusion of sugars and polyols from native state IgG1 and its effect on monoclonal antibody aggregation and reversible self-association. Pharm Res. 2019;36:109.
- Arora J, Hu Y, Esfandiary R, Sathish HA, Bishop SM, Joshi SB, Middaugh CR, Volkin DB, Weis DD. Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosity. MAbs. 2016;8:1561–74. doi:https://doi.org/10.1080/19420862.2016.1222342.
- Mackerell AD, Feig M, Brooks CL. Extending the treatment of backbone energetics in protein force fields: limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulation. J Comput Chem. 2004;25:1400–15. doi:https://doi.org/10.1002/jcc.20065.
- Horn AHC. A consistent force field parameter set for zwitterionic amino acid residues. J Mol Model. 2014;20:2478. doi:https://doi.org/10.1007/s00894-014-2478-z.
- Campo MG. Molecular dynamics simulation of glycine zwitterion in aqueous solution. J Chem Phys. 2006;125:114511. doi:https://doi.org/10.1063/1.2352756.
- Best RB, Zhu X, Shim J, Lopes PEM, Mittal J, Feig M, MacKerell AD. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone ϕ, ψ and side-chain χ1 and χ2 dihedral angles. J. Chem. Theory Comput. 2012;8:3257–73. doi:https://doi.org/10.1021/ct300400x.
- Goldberg DS, Lewus RA, Esfandiary R, Farkas DC, Mody N, Day KJ, Mallik P, Tracka MB, Sealey SK, Samra HS, et al. Utility of high throughput screening techniques to predict stability of monoclonal antibody formulations during early stage development. J. Pharm. Sci. 2017;106:1971–77. doi:https://doi.org/10.1016/j.xphs.2017.04.039.
- Bhambhani A, Kissmann JM, Joshi SB, Volkin DB, Kashi RS, Middaugh CR. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions. Journal of Pharmaceutical Sciences. 2012;101:1120–35 3 doi:https://doi.org/10.1002/jps.23008
- Bhattacharyya R, Chakrabarti P. Stereospecific interactions of proline residues in protein structures and complexes. J Mol Biol. 2003;331:925–40. doi:https://doi.org/10.1016/S0022-2836(03)00759-9.
- Wu W, Raleigh DP. Local control of peptide conformation: stabilization of cis proline peptide bonds by aromatic proline interactions. Biopolymers. 1998;45:381–94. doi:https://doi.org/10.1002/(SICI)1097-0282(19980415)45:5<381::AID-BIP6>3.0.CO;2-H.
- Zondlo NJ. Aromatic-proline interactions: electronically tunable CH/π interactions. Acc Chem Res. 2013;46:1039–49.
- Alekseychyk L, Su C, Becker GW, Treuheit MJ, Razinkov VI. High-throughput screening and stability optimization of anti-streptavidin IgG1 and IgG2 formulations. J Biomol Screen. 2014;19:1290–301. doi:https://doi.org/10.1177/1087057114542431.
- Vagenende V, Han AX, Mueller M, Trout BL. Protein-associated cation clusters in aqueous arginine solutions and their effects on protein stability and size. ACS Chem Biol. 2013;8:416–22. doi:https://doi.org/10.1021/cb300440x.
- Březina K, Duboué-Dijon E, Palivec V, Jiráček J, Křížek T, Viola CM, Ganderton TR, Brzozowski AM, Jungwirth P. Can arginine inhibit insulin aggregation? A combined protein crystallography, capillary electrophoresis, and molecular simulation study. J Phys Chem B. 2018;122:10069–76. doi:https://doi.org/10.1021/acs.jpcb.8b06557.
- Crowley PB, Golovin A. Cation-π interactions in protein-protein interfaces. Proteins Struct Funct Genet. 2005;59:231–39. doi:https://doi.org/10.1002/prot.20417.
- Hong J, Capp MW, Anderson CF, Saecker RM, Felitsky DJ, Anderson MW, Record MT. Preferential interactions of glycine betaine and of urea with DNA: implications for DNA hydration and for effects of these solutes on DNA stability†. Biochemistry. 2004;43:14744–58. doi:https://doi.org/10.1021/bi049096q.
- He F, Woods CE, Becker GW, Narhi LO, Razinkov VI. High-throughput assessment of thermal and colloidal stability parameters for monoclonal antibody formulations. J Pharm Sci. 2011;100:5126–41. doi:https://doi.org/10.1002/jps.22712.
- Brandt JP, Patapoff TW, Aragon SR. Construction, MD simulation, and hydrodynamic validation of an all-atom model of a monoclonal IgG antibody. Biophys J. 2010;99:905–13.
- Sircar A, Kim ET, Gray JJ. RosettaAntibody: antibody variable region homology modeling server. Nucleic Acids Res. 2009;37:474–79. doi:https://doi.org/10.1093/nar/gkp387.
- Padlan EA. Anatomy of the antibody molecule. Mol Immunol. 1994;31:169–217. doi:https://doi.org/10.1016/0161-5890(94)90001-9.
- Abraham MJ, Murtola T, Schulz R, Páll S, Smith JC, Hess B, Lindahl E. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1–2:19–25. doi:https://doi.org/10.1016/j.softx.2015.06.001.
- Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79:926–35. doi:https://doi.org/10.1063/1.445869.
- Dolinsky TJ, Czodrowski P, Li H, Nielsen JE, Jensen JH, Klebe G, Baker NA. PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res. 2007;35:W522–W525
- Baynes BM, Trout BL. Proteins in mixed solvents: a molecular-level perspective. J Phys Chem B. 2003;107:14058–67. doi:https://doi.org/10.1021/jp0363996.
- Shukla D, Shinde C, Trout BL. Molecular computations of preferential interaction coefficients of proteins. J Phys Chem B. 2009;113:12546–54. doi:https://doi.org/10.1021/jp810949t.